San Marcos, CA, United States of America

Alan D Agulnick

USPTO Granted Patents = 38 

 

 

Average Co-Inventor Count = 3.3

ph-index = 18

Forward Citations = 1,517(Granted Patents)


Location History:

  • San Marcos, CA (US) (2009 - 2012)
  • San Digeo, CA (US) (2018)
  • San Diego, CA (US) (2010 - 2024)

Company Filing History:


Years Active: 2009-2024

Loading Chart...
Loading Chart...
Loading Chart...
38 patents (USPTO):Explore Patents

Title: Alan D. Agulnick: Pioneering Innovations in Stem Cell Technology

Introduction

Alan D. Agulnick, based in San Marcos, CA, is a distinguished inventor with an impressive portfolio of 38 patents. His innovative contributions primarily focus on advancements in stem cell technology and cell-based therapies, making significant impacts in the medical field.

Latest Patents

Among his latest patents are two notable inventions. The first is a "Cell encapsulation device comprising a pancreatic progenitor cell population," which includes cell culture compositions derived from dedifferentiated human reprogrammed pluripotent stem cells, such as induced pluripotent stem (iPS) cells. This invention details methods for producing and utilizing these specific cell culture compositions.

The second patent, "Universal donor cells and related methods," introduces universal donor stem cells, which are crucial for overcoming allogeneic immune rejection in cell-based transplantation therapies. These universal donor cells are designed such that they do not express certain MHC-Class I cell-surface proteins, thereby enhancing their compatibility for transplantation purposes.

Career Highlights

Throughout his career, Alan has worked with leading biotech companies including Viacyte, Inc. and Cythera, Inc. His work has been pivotal in the development of therapies that leverage stem cells for regenerative medicine, marking him as a prominent figure in the industry.

Collaborations

Alan D. Agulnick has collaborated with notable professionals such as Kevin Allen D'Amour and Emmanuel Edward Baetge. These collaborations have further expanded the scope of his innovation, blending expertise to address complex challenges in stem cell research and therapeutic applications.

Conclusion

With a robust portfolio of patents and valuable contributions to the field of stem cell technology, Alan D. Agulnick exemplifies the spirit of innovation. His dedication to enhancing medical therapies through scientific advancements continues to influence the future of regenerative medicine and transplantation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…